Skip to main content
SpringerLink
Log in

Identification of sentinel lymph node in breast cancer by lymphoscintigraphy and surgical gamma probe with peritumoral injection of scintimammographic agent “99mTc MIBI”

  • Original Articles
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

The purpose of this study was to evaluate the efficacy of lymphoscintigraphy and the surgical gamma probe (SGP) with peritumoral injection of99mTc MIBI in sentinel lymph node (SLN) detection in breast cancer regardless of whether metastatic or notMethod: Thirty patients with T1/T2 breast cancer had peritumoral injections of99mTc MIBI (74 MBq/0.2 ml at 4 different locations) at 2, 6 and 24 hours before surgery. Anterior, anterolateral, and lateral spot images were taken at 10, 30, 45, 60 and 120 minutes. Counts were collected from the injection site, affected breast tissue, internal mammaries, axillary and supraclavicular regions, and the contralateral side. Peritumoral blue dye was also injected at surgery. The first lymph nodes with counts twice the background tissue and/or with blue dye uptake were surgically isolated, and histopathological evaluations were made. Modified radical mastectomy was performed on all patients.Results: 23/30 patients had lymph nodes in scintigrams and the sentinel lymph nodes were identified with SGP in 25/30 patients.Conclusion: Lymphoscintigraphy and subsequent SGP detection with peritumoral injection of99mTc MIBI can be used for identifying SLN in breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1989 to January 1994.Johns Hopkins Hops Bull 1994–1995; 4: 297–323.

    Google Scholar 

  2. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment.Breast Cancer Res Treat 1985; 5: 17–21.

    Article  PubMed  CAS  Google Scholar 

  3. Harris JR, Hellman S. Natural history of breast cancer. In: Harris JR, Lippman ME, Morrow M, Hellman S, eds.Diseases of the Breast. Philadelphia; Lippincott-Raven, 1996.

    Google Scholar 

  4. Veronesi U, Rilke F, Luini A, Sacchini V, Galimberti V, Campa T, et al. Distribution of axillary node metastases by level of invasion. An analysis of 539 cases.Cancer 1987; 59: 682–687.

    CAS  Google Scholar 

  5. Danforth DN Jr, Findlay PA, McDonald HD, Lippman ME, Reichert CM, d'Angelo T, et al. Complete axillary lymph node dissection for stage I–II carcinoma of the breast.J Clin Oncol 1986; 4: 655–662.

    PubMed  Google Scholar 

  6. Siegel BM, Mayzel KA, Love SM. Level I and II axillary dissection in the treatment of early-stage breast cancer: an analysis of 259 consecutive patients.Arch Surg 1990; 125: 1144–1147.

    PubMed  CAS  Google Scholar 

  7. Senofsky GM, Moffat FL, Davis K, Masri MM, Clark KF, Robinson DS. Total axillary lymphadenectomy in the management of breast cancer.Arch Surg 1991; 126: 1336–1342.

    PubMed  CAS  Google Scholar 

  8. Kissin MW, Thompson EM, Price AB, Slavin G, Kark AE. The inadequacy of axillary sampling in breast cancer.Lancet 1982; 2: 1210–1212.

    Article  Google Scholar 

  9. Davies GC, Millis RR, Hayward JL. Assessment of axillary lymph node status.Ann Surg 1980; 192: 148–151.

    Article  PubMed  CAS  Google Scholar 

  10. Larson D, Weinstein M, Goldberg I, Silver B, Recht A, Cady B. Edema of the arm as a function of the extent of axillary surgery in patients with Stage I–II carcinoma of the breast treated with primary radiotherapy.Int J Radiat Oncol Biol Phys 1986; 12: 1575–1582.

    PubMed  CAS  Google Scholar 

  11. Ryttov N, Holm NV, Qvist N, Blichert-Toft M. Influence of adjuvant irradiation on the development of late arm lymphedema and impaired shoulder mobility after mastectomy for carcinoma of the breast.Acta Oncol 1988; 27; 667–671.

    Article  PubMed  CAS  Google Scholar 

  12. Ivens D, Hoe AL, Podd TJ, Hamilton OR, Taylor J Royle GT, et al. Assessment of morbidity from complete axillary dissection.Br J Cancer 1992; 66: 136–138.

    PubMed  CAS  Google Scholar 

  13. Dixon M. Sentinel node biopsy in breast cancer.Br Med J 1998; 317: 295–296.

    CAS  Google Scholar 

  14. Della Rovere G, Bird PA. Sentinel-lymph-node in breast cancer.Lancet 1998; 352: 421–422.

    Article  Google Scholar 

  15. van Der Wall E. The sentinel node in breast cancer: implications for adjuvant treatment?Eur J Nucl Med 1999; 26 (Suppl): 17–19. (abstract)

    Article  Google Scholar 

  16. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer.Lancet 1997; 349; 1668–1669.

    Article  PubMed  CAS  Google Scholar 

  17. Flett MM, Going JJ, Stanton DD, Cooke TG. Sentinel node localization in patients with breast cancer.Br J Surg 1998; 85 (7): 991–993.

    Article  PubMed  CAS  Google Scholar 

  18. Uren RF, Howman-Gilers RB, Thompson JF. Mammary lymphoscintigraphy in breast cancer.J Nucl Med 1995; 36: 1775–1780.

    PubMed  CAS  Google Scholar 

  19. Ege GN. Lymphoscintigraphy, techniques and application in the management of breast carcinoma.Semin Nucl Med 1983; 13: 26–34.

    Article  PubMed  CAS  Google Scholar 

  20. Gill PG, Hall VE, Kirkwood I, Chatterton BE, Coventry B, Vernon-Roberts E. Lymphoscintigraphy for locating the sentinel lymph node in patients with breast cancer.Breast 1997; 6: 225. (abstract)

    Article  Google Scholar 

  21. Kapteijn AE, Nieweg OE, Petersen JL, Rutgers EJ, Hart AA, Van Dongen JA, et al. Identification and biopsy of the sentinel node in breast cancer.Eur J Surg Oncol 1998; 24: 427–430.

    Article  PubMed  CAS  Google Scholar 

  22. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe.Surg Oncol 1993; 2: 335–340.

    Article  PubMed  CAS  Google Scholar 

  23. Borgstein PJ, Pijpers R, Comans EF, Van Diest PS, Boom RP, Meijer S, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.J Am Coll Surg 1998; 186: 275–283.

    Article  PubMed  CAS  Google Scholar 

  24. Khalkhali I, Cutrone JA, Mena IG, Diggles LE, Venegas RJ, Vargas HI. Scintimammography: The complementary role of99mTc Sestamibi prone breast imaging for the diagnosis of breast carcinoma.Radiology 1995; 196: 421–426.

    PubMed  CAS  Google Scholar 

  25. Burak Z, Argon M, Memis A, Erdem S, Balkan Z, Duman Y. Evaluation of palpable breast masses with99mTc MIBI: A comparative study with mammography and ultrasonography.Nucl Med Commun 1994; 15: 604–612.

    PubMed  CAS  Google Scholar 

  26. Kao C, Wang S, Liu T. The use of99mTc methoxybutylisonitrile breast scintigraphy to evaluate palpable breast masses.Eur J Nucl Med 1994; 21: 432–436.

    PubMed  CAS  Google Scholar 

  27. Maffioli L, Agresti R, Chiti A, Crippa F, Gasparini M, Greco M, et al. Prone, scintimammography in patients with non-palpable breast lesions.Anticancer Res 1996; 16: 1269–1274.

    PubMed  CAS  Google Scholar 

  28. Palmedo I, Schonburg A, Grunwald F, Mallmann P, Krebs D, Biersach HJ.99mTc MIBI scintimammography for suspicious breast lesions.J Nucl Med 1996; 37: 626–674.

    PubMed  CAS  Google Scholar 

  29. Khalkhali I, Iraniha S, Diggles LE, Cutrone JA, Mishkin FS: Scintimammography: the new role of Technetium-99m Sestamibi imaging for the diagnosis of breast carcinoma.The Quart J Nucl Med 1997; 41: 231–238.

    CAS  Google Scholar 

  30. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J.99mTechnetium Sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.J Nucl Med 1995; 36: 52 (abstract)

    Google Scholar 

  31. Lam WWM, Yang WT, Chan YL, Stewart IET, Metrevelli C, King W. Detection of axillary lymph node metastases in breast carcinoma by99mTc MIBI breast scintigraphy ultrasound and conventional mammography.Eur J Nucl Med 1996; 23: 498–503.

    Article  PubMed  CAS  Google Scholar 

  32. Maffioli LS, Seregni E, Chiesa C, Nerini-Molteni S, Gerali A, Bombardieri E. Detection of lymph node metastases by lymphoscintigraphy with a tumour-seeking tracer in breast cancer patients.Eur J Nucl Med 2000; 27: 744–746.

    PubMed  CAS  Google Scholar 

  33. Uren RF, Howman-Giles RB, Thompson JF. The value of pre-operative lymphoscintigraphy in breast cancer treatment.Eur J Cancer 1998; 34: 203–204.

    Article  PubMed  CAS  Google Scholar 

  34. De Cicco C, Cremonesi M, Luini A, Bertolomei M, Grana C, Drisco G, et al. Lymphoscintigraphy and Radioguided Biopsy of the Sentinel axillary node in breast cancer.J Nucl Med 1998; 39 (12): 2080–2084.

    PubMed  Google Scholar 

  35. Mariani G, Villa G, Gipponi M, Bianchi P, Buffoni F, Agnese G, et al. Mapping sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue dye, and intraoperative gamma probe.Cancer Biother Radiopharm 2000; 15 (3): 245–250.

    Article  PubMed  CAS  Google Scholar 

  36. Giuliano AE. Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection.J Surg Oncol 1996; 62: 75–77.

    Article  PubMed  CAS  Google Scholar 

  37. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.Ann Surg 1998; 227: 645–653.

    Article  PubMed  CAS  Google Scholar 

  38. Nieweg OE, Jansen L, Yaldes Olmos RA, Rutgers EJ, Peterse JL, Hoefnagel KA, et al. Lymphatic mapping and sentinel lymph node biopsy in breast cancer.Eur J Nucl Med 1999; 26 (suppl): S11–16.

    Article  Google Scholar 

  39. Van der Ent FWC, Kengen RAM, Van der Pol HAG, Hoofwijk AGM. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with ablue dye tracer.Eur J Surg Oncol 1999; 25: 24–29.

    Article  PubMed  Google Scholar 

  40. Kramer L. Lymphoscintigraphy: Radiopharmaceutical Selection and Methods.Nucl Med Biol 1990; 17 (1): 57–63.

    CAS  Google Scholar 

  41. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patients with breast cancer.JAMA 1996; 276: 1818–1822.

    Article  PubMed  CAS  Google Scholar 

  42. Donahue EJ. Sentinel node imaging and biopsy in breast cancer patients.Am J Surg 2001; 182 (4): 426–428.

    Article  PubMed  CAS  Google Scholar 

  43. Kern KA. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.J Am Coll Surg 1999; 189: 539–545.

    Article  PubMed  CAS  Google Scholar 

  44. Freneaux P, Nos C, Charvolin JY, Vincent-Salomon A, Zafrani B, Salmon RJ, et al. Value of macroscopic analysis for identification of axillary sentinel nodes detected by potent blue dye alone during breast cancer surgery.Ann Pathol 2000; 20: 545–548.

    PubMed  CAS  Google Scholar 

  45. Ilum L, Bak M, Olsen KE, Kryh D, Berg V, Axelsson CK. Sentinel node localization in breast cancer patients using intradermal dye injection.Acta Oncol 2000; 39: 423–428.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Ankara University Medical Faculty, 06100, Ankara, Turkey

    G. Aras, P. Arican, N. Ö. Küçük, E. Ibiş & A. Soylu

  2. Department of Surgery, Ankara University Medical Faculty, Ankara, Turkey

    R. Çam & A. Tüzüner

Authors
  1. G. Aras
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Arican
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Çam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Ö. Küçük
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Ibiş
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Tüzüner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Soylu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Aras.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aras, G., Arican, P., Çam, R. et al. Identification of sentinel lymph node in breast cancer by lymphoscintigraphy and surgical gamma probe with peritumoral injection of scintimammographic agent “99mTc MIBI”. Ann Nucl Med 16, 121–126 (2002). https://doi.org/10.1007/BF02993715

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02993715

Key words

Search

Navigation